A Relative Bioavailability Study Evaluating Two New Encorafenib Formulations

Conditions

• Healthy

Interventions

• DRUG: Encorafenib capsule formulation (CAP)
• DRUG: Encorafenib first formulation
• DRUG: Encorafenib second formulation
• DRUG: Rabeprazole tablet

Sponsor

Pfizer

Collaborators

• [object Object]
• [object Object]